These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24643720)

  • 1. Underestimation of myelodysplastic syndrome incidence by cancer registries: Results from a population-based data linkage study.
    McQuilten ZK; Wood EM; Polizzotto MN; Campbell LJ; Wall M; Curtis DJ; Farrugia H; McNeil JJ; Sundararajan V
    Cancer; 2014 Jun; 120(11):1686-94. PubMed ID: 24643720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelodysplastic syndrome incidence, transfusion dependence, health care use, and complications: an Australian population-based study 1998 to 2008.
    McQuilten ZK; Polizzotto MN; Wood EM; Sundararajan V
    Transfusion; 2013 Aug; 53(8):1714-21. PubMed ID: 23305556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High rate of uncaptured myelodysplastic syndrome cases and an improved method of case ascertainment.
    Cogle CR; Iannacone MR; Yu D; Cole AL; Imanirad I; Yan L; Mackinnon JA; List AF; Rollison DE
    Leuk Res; 2014 Jan; 38(1):71-5. PubMed ID: 24280283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelodysplastic syndrome in New Zealand and Australia.
    Rodger EJ; Morison IM
    Intern Med J; 2012 Nov; 42(11):1235-42. PubMed ID: 22032810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and prevalence of myelodysplastic syndromes: data from the Düsseldorf MDS-registry.
    Neukirchen J; Schoonen WM; Strupp C; Gattermann N; Aul C; Haas R; Germing U
    Leuk Res; 2011 Dec; 35(12):1591-6. PubMed ID: 21708407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in incidence, initial treatment and survival of myelodysplastic syndromes: a population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010.
    Dinmohamed AG; Visser O; van Norden Y; Huijgens PC; Sonneveld P; van de Loosdrecht AA; Jongen-Lavrencic M
    Eur J Cancer; 2014 Mar; 50(5):1004-12. PubMed ID: 24388662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy-related acute myeloid leukaemia and myelodysplastic syndrome in Victoria, Australia 2003-2014.
    Ong DM; Farrugia H; Wei A
    Intern Med J; 2018 Jul; 48(7):822-829. PubMed ID: 29236346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of myelodysplastic syndromes within a nonprofit healthcare system in western Washington state, 2005-2006.
    De Roos AJ; Deeg HJ; Onstad L; Kopecky KJ; Bowles EJ; Yong M; Fryzek J; Davis S
    Am J Hematol; 2010 Oct; 85(10):765-70. PubMed ID: 20815079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological data from the registry of patients with myelodysplastic syndrome in a single hospital center of Romania.
    Gologan R; Georgescu D; Tatic A; Radulescu I; Vasilache D
    Leuk Res; 2009 Nov; 33(11):1556-61. PubMed ID: 19411107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clustering in the incidence of myelodysplastic syndromes.
    Ma X; Selvin S; Raza A; Foti K; Mayne ST
    Leuk Res; 2007 Dec; 31(12):1683-6. PubMed ID: 17507092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent improvement in completeness of incidence data on acute myeloid leukemia in US cancer registries.
    Polednak AP
    J Registry Manag; 2014; 41(2):77-84. PubMed ID: 25153013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelodysplastic syndromes: incidence and survival in the United States.
    Ma X; Does M; Raza A; Mayne ST
    Cancer; 2007 Apr; 109(8):1536-42. PubMed ID: 17345612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population-based study of survival in patients with secondary myelodysplastic syndromes (MDS): impact of type and treatment of primary cancers.
    De Roos AJ; Deeg HJ; Davis S
    Cancer Causes Control; 2007 Dec; 18(10):1199-208. PubMed ID: 17823848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long term risk of myelodysplastic syndromes among anemia patients: a population-based study.
    Meytes D; Chodick G; Shalev V; Porath A
    Leuk Res; 2012 Mar; 36(3):327-30. PubMed ID: 22142797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemia as a cause of death among patients with myelodysplastic syndromes (MDS) in a population- based cancer registry: improving estimates of MDS-related mortality in the population.
    Polednak AP; Phillips C
    J Registry Manag; 2012; 39(3):115-20. PubMed ID: 23443455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myelodysplastic syndromes. The epidemiological and etiological aspects].
    Aul C; Gattermann N; Germing U; Runde V; Heyll A
    Dtsch Med Wochenschr; 1992 Aug; 117(33):1223-31. PubMed ID: 1499520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological data on myelodysplastic syndrome patients under 50 years in a single center of Romania.
    Gologan R
    Leuk Res; 2010 Nov; 34(11):1442-6. PubMed ID: 20189246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study.
    Kaplan H; Malmgren J; De Roos AJ
    Breast Cancer Res Treat; 2013 Feb; 137(3):863-7. PubMed ID: 23274844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries.
    Cogle CR; Craig BM; Rollison DE; List AF
    Blood; 2011 Jun; 117(26):7121-5. PubMed ID: 21531980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coding of specific subgroups of myelodysplastic syndromes in a population-based cancer registry: prospects for improvement.
    Polednak AP; Phillips C
    J Registry Manag; 2012; 39(3):107-14. PubMed ID: 23443454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.